1、 ZHOU L, LUAN H, LIU Q, et al. Activation of PI3K/Akt and ERK signaling pathways antagonized sinomenine-induced lung cancer cell apoptosis [J]. Mol Med Rep, 2012, 5(5): 1256-1260. ZHOU L, LUAN H, LIU Q, et al. Activation of PI3K/Akt and ERK signaling pathways antagonized sinomenine-induced lung cancer cell apoptosis [J]. Mol Med Rep, 2012, 5(5): 1256-1260.
2、 LIU Z, DUAN Z J, CHANG J Y, et al. Sinomenine sensitizes multidrug-resistant colon cancer cells (Caco-2) to doxorubicin by downregulation of MDR-1 expression [J]. PLoS One, 2014, 9(6): e98560. LIU Z, DUAN Z J, CHANG J Y, et al. Sinomenine sensitizes multidrug-resistant colon cancer cells (Caco-2) to doxorubicin by downregulation of MDR-1 expression [J]. PLoS One, 2014, 9(6): e98560.
3、 QU X, YU B, ZHU M, et al. Sinomenine inhibits the growth of ovarian cancer cells through the suppression of mitosis by down-regulating the expression and the activity of CDK1 [J]. Onco Targets Ther, 2021(14): 823-834. QU X, YU B, ZHU M, et al. Sinomenine inhibits the growth of ovarian cancer cells through the suppression of mitosis by down-regulating the expression and the activity of CDK1 [J]. Onco Targets Ther, 2021(14): 823-834.
4、 LI X, LI P, LIU C, et al. Sinomenine hydrochloride inhibits breast cancer metastasis by attenuating inflammation-related epithelial-mesenchymal transition and cancer stemness [J]. Oncotarget, 2017, 8(8): 13560-13574. LI X, LI P, LIU C, et al. Sinomenine hydrochloride inhibits breast cancer metastasis by attenuating inflammation-related epithelial-mesenchymal transition and cancer stemness [J]. Oncotarget, 2017, 8(8): 13560-13574.
5、 LIU W, ZHANG Y, ZHU W, et al. Sinomenine inhibits the progression of rheumatoid arthritis by regulating the secretion of inflammatory cytokines and monocyte/macrophage subsets [J]. Front Immunol, 2018(9): 2228. LIU W, ZHANG Y, ZHU W, et al. Sinomenine inhibits the progression of rheumatoid arthritis by regulating the secretion of inflammatory cytokines and monocyte/macrophage subsets [J]. Front Immunol, 2018(9): 2228.
6、 LEE J Y, KIM K J, KIM J, et al. Anti-osteoclastogenic effects of isoquinoline alkaloids from the rhizome extract of Sinomenium acutum [J]. Arch Pharm Res, 2016, 39(5): 713-20. LEE J Y, KIM K J, KIM J, et al. Anti-osteoclastogenic effects of isoquinoline alkaloids from the rhizome extract of Sinomenium acutum [J]. Arch Pharm Res, 2016, 39(5): 713-20.
7、 陆淼炯,褚卫建. 魔芋葡甘露聚糖逆转大肠癌5-氟尿嘧啶耐药的作用及其机制研究[J]. 中国现代应用药学,2021,38(10):1188-1194. 陆淼炯,褚卫建. 魔芋葡甘露聚糖逆转大肠癌5-氟尿嘧啶耐药的作用及其机制研究[J]. 中国现代应用药学,2021,38(10):1188-1194.
8、 鹿蓓蓓,傅鹤秀,ERIC ACHIBOREBADOR OKRAH 等,穿心莲内酯对小鼠乳腺癌的抑制作用和机制[J]. 中国药理学通报,2022,38(1):26-32. 鹿蓓蓓,傅鹤秀,ERIC ACHIBOREBADOR OKRAH 等,穿心莲内酯对小鼠乳腺癌的抑制作用和机制[J]. 中国药理学通报,2022,38(1):26-32.
9、 RATHMELL W K, GODLEY P A. Recent updates in renal cell carcinoma [J]. Curr Opin Oncol,2010, 22(3):250-256. RATHMELL W K, GODLEY P A. Recent updates in renal cell carcinoma [J]. Curr Opin Oncol,2010, 22(3):250-256.
10、 LJUNGBERG B, CAMPBELL S C, CHOI H Y, et al. The epidemiology of renal cell carcinoma [J]. Eur Urol, 2011, 60(4):615-621. LJUNGBERG B, CAMPBELL S C, CHOI H Y, et al. The epidemiology of renal cell carcinoma [J]. Eur Urol, 2011, 60(4):615-621.
11、 LINEHAN W M. Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics [J]. Genome Res,2012, 22(11):2089-100. LINEHAN W M. Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics [J]. Genome Res,2012, 22(11):2089-100.
12、 MAURANO M T, RICHARD H, ERIC R, et al. Systematic localization of common disease-associated variation in regulatory DNA [J]. Science, 2012, 337(6099):1190-1195. MAURANO M T, RICHARD H, ERIC R, et al. Systematic localization of common disease-associated variation in regulatory DNA [J]. Science, 2012, 337(6099):1190-1195.
13、 LV Y, LI C, LI S, et al. Sinomenine inhibits proliferation of SGC-7901 gastric adenocarcinoma cells via suppression of cyclooxygenase-2 expression [J]. Oncol Lett, 2011, 2(4): 741-745. LV Y, LI C, LI S, et al. Sinomenine inhibits proliferation of SGC-7901 gastric adenocarcinoma cells via suppression of cyclooxygenase-2 expression [J]. Oncol Lett, 2011, 2(4): 741-745.
14、 王昊,刘天盛,陈旭义. 青藤碱对胶原诱导性关节炎大鼠治疗作用 [J]. 中华实用诊断与治疗杂志, 2015, 29(6): 535-537. 王昊,刘天盛,陈旭义. 青藤碱对胶原诱导性关节炎大鼠治疗作用 [J]. 中华实用诊断与治疗杂志, 2015, 29(6): 535-537.
15、 罗进芳,朱易浪,董燕,等.青藤碱对LPS、IL-4诱导的小鼠RAW264.7巨噬细胞极化的影响 [J]. 中国免疫学杂志, 2015, 31(1):56-60. 罗进芳,朱易浪,董燕,等.青藤碱对LPS、IL-4诱导的小鼠RAW264.7巨噬细胞极化的影响 [J]. 中国免疫学杂志, 2015, 31(1):56-60.
16、 ZHU Q, SUN Y, MAO L, et al. Antinociceptive effects of sinomenine in a rat model of postoperative pain [J]. Br J Pharmacol, 2016, 173(10): 1693-1702. ZHU Q, SUN Y, MAO L, et al. Antinociceptive effects of sinomenine in a rat model of postoperative pain [J]. Br J Pharmacol, 2016, 173(10): 1693-1702.
17、 LIU S, MAN Y, ZHAO L. Sinomenine inhibits lipopolysaccharide-induced inflammatory injury by regulation of miR-101/MKP-1/JNK pathway in keratinocyte cells [J]. Biomed Pharmacother, 2018(101): 422-429. LIU S, MAN Y, ZHAO L. Sinomenine inhibits lipopolysaccharide-induced inflammatory injury by regulation of miR-101/MKP-1/JNK pathway in keratinocyte cells [J]. Biomed Pharmacother, 2018(101): 422-429.
18、 ZHAO M M, YANG B, ZHANG Q, et al. Sinomenine hydrochloride attenuates renal fibrosis by inhibiting excessive autophagy induced by adriamycin: an experimental study [J]. Evid Based Complement Alternat Med, 2017(2017): 6878795. ZHAO M M, YANG B, ZHANG Q, et al. Sinomenine hydrochloride attenuates renal fibrosis by inhibiting excessive autophagy induced by adriamycin: an experimental study [J]. Evid Based Complement Alternat Med, 2017(2017): 6878795.
19、 张洪长, 刘明昕, 张莹,等.青藤碱对类风湿关节炎成纤维样滑膜细胞MyD88、TRAF-6表达的影响 [J]. 中国免疫学杂志, 2015(4): 485-489. 张洪长, 刘明昕, 张莹,等.青藤碱对类风湿关节炎成纤维样滑膜细胞MyD88、TRAF-6表达的影响 [J]. 中国免疫学杂志, 2015(4): 485-489.
20、 YAMASAKI H. Pharmacology of sinomenine, an anti-rheumatic alkaloid from Sinomenium acutum [J]. Acta Med Okayama, 1976, 30(1): 1-20. YAMASAKI H. Pharmacology of sinomenine, an anti-rheumatic alkaloid from Sinomenium acutum [J]. Acta Med Okayama, 1976, 30(1): 1-20.
